MEDICINA PREVENTIVA, SALUD PÚBLICA Y M.M
Departamento
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (4)
2000
-
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics
Journal of Antimicrobial Chemotherapy, Vol. 46, Núm. 4, pp. 557-564
1999
-
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 357-359
-
Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 178-180
-
Antimicrobial susceptibility of 1422 Haemophilus influenzae isolates from respiratory tract infections in Spain. Results of a 1 year (1996-97) multicenter surveillance study
Infection, Vol. 27, Núm. 4-5, pp. 265-267